9 results found

The high-profile litigation between xAI and OpenAI has reached a significant turning point, with Judge Rita Lin of the Northern District of California...

Imagine a pharmaceutical company that deploys a network of AI agents to accelerate early-stage drug discovery.

Two recent trade secret lawsuits against OpenAI reveal the critical difference between viable and dismissible claims under the Defend Trade Secrets Act. While xAI's case was dismissed and now faces a million-dollar fee demand, Apple's complaint demonstrates how to properly plead active acquisition, documented knowledge, and directed exfiltration in talent-raiding disputes.

For most of the past year, when AI companies have talked about distillation, they have talked about it as a Chinese problem. In February 2026, OpenAI told the House Select Committee on China that DeepSeek...

The xAI v. OpenAI litigation has taken another significant turn.

The dismissal of xAI's trade secret claims against OpenAI earlier this month meant that the court never reached what will surely be one of the thorniest questions in AI trade secret litigation...

Massachusetts House Bill H. 2090 proposes a significant expansion of the state's employment laws by extending protections — specifically regarding restrictive covenants like noncompetes...